Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies

Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies

<p>Abstract</p> <p>Background</p> <p>The impact of once daily atomoxetine treatment on symptoms in children and adolescents with ADHD may vary over the day. In order to capture such variations, two studies were undertaken in children and adolescents with ADHD using two...

Full description

Bibliographic Details
Main Authors:	Schacht Alexander, Helsberg Karin, Dittmann Ralf W, Wehmeier Peter M, Lehmkuhl Gerd
Format:	Article
Language:	English
Published:	BMC 2009-02-01
Series:	Child and Adolescent Psychiatry and Mental Health
Online Access:	http://www.capmh.com/content/3/1/5

Similar Items

Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians
by: Lehmann Martin, et al.
Published: (2009-08-01)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
by: Rubin Richard, et al.
Published: (2009-12-01)

Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).
by: Su Jin Moon, et al.
Published: (2014-01-01)

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials
by: Schacht Alexander, et al.
Published: (2010-12-01)

Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS)
by: Dittmann Ralf W, et al.
Published: (2008-05-01)

Atomoxetine and Methylphenidate Treatment in ADHD
by: Snircova E., et al.
Published: (2015-05-01)

A critical appraisal of atomoxetine in the management of ADHD
by: Childress AC
Published: (2015-12-01)

Is atomoxetine effective in some comorbid mental disorders in ADHD?
by: Cesneková D., et al.
Published: (2016-09-01)

Once-daily medications for the pharmacological management of ADHD in adults
by: Oleg v Tcheremissine, et al.
Published: (2009-05-01)

Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: Reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day
by: Dittmann Ralf W, et al.
Published: (2008-05-01)

Morning and evening talk /
by: Mahfouz, Naguib, 1911-, et al.
Published: (2007)

Morning and evening exercise
by: Dae Yun Seo, et al.
Published: (2013-12-01)

Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder
by: Tsutomu Nagai, et al.
Published: (2022-09-01)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
by: Paul Hammerness, et al.
Published: (2009-03-01)

Analyzing Black Market Sales of the Second-Line ADHD Medication Atomoxetine
by: Sophie A. Roe, et al.
Published: (2023-11-01)

Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats
by: Mahmoud H. Teaima, et al.
Published: (2023-02-01)

Sex in the morning or in the evening? Females adjust daily mating patterns to the intensity of sexual harassment.
by: Løvlie, H, et al.
Published: (2007)

Atomoxetine induced hypomania in a patient with bipolar disorder and adult attention deficit hyperactivity disorder
by: Vijaya Kumar, et al.
Published: (2017-01-01)

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
by: Woodcock Ashley, et al.
Published: (2011-12-01)

Color Preferences for Morning and Evening Chronotypes
by: Viera Guzoňová, et al.
Published: (2022-05-01)

Light triggers a network switch between circadian morning and evening oscillators controlling behaviour during daily temperature cycles.
by: Clara Lorber, et al.
Published: (2022-11-01)

Treatment of Hypertension: Favourable Effect of the Twice-Daily Compared to the Once-Daily (Evening) Administration of Perindopril and Losartan
by: Ipoly Szauder, et al.
Published: (2015-07-01)

Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis
by: Reimherr Fred, et al.
Published: (2005-10-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
by: Joseph A, et al.
Published: (2016-03-01)

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder
by: Cao P, et al.
Published: (2018-11-01)

Attention-Deficit/Hyperactivity Disorder (ADHD)
by: Garret D. Evans, et al.
Published: (2006-08-01)

Asymmetric time interval between evening and morning milking and its effect on the total daily milk yield
by: Gustav Chládek, et al.
Published: (2011-01-01)

The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder
by: Serkan Turan, et al.
Published: (2019-10-01)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
by: Clemow DB, et al.
Published: (2017-02-01)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
by: Dilla Tatiana, et al.
Published: (2009-04-01)

Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
by: Yoko Nakanishi, et al.
Published: (2017-05-01)

Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients
by: Julia R Smith, et al.
Published: (2018-08-01)

Effectiveness and safety of atomoxetine for ADHD in population between 6 and 19 years: a systematic review
by: José Calleja, et al.
Published: (2012-09-01)

Acute atomoxetine treatment of younger and older children with ADHD: A meta-analysis of tolerability and efficacy
by: Vaughan Brigette S, et al.
Published: (2008-09-01)

ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) – THERAPY
by: Valeriu Popescu
Published: (2008-06-01)

Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
by: Satoshi Kasahara, et al.
Published: (2023-08-01)

Atomoxetine in the Treatment of the Most Common Comorbid Disorders of Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder and Anxiety Disorders
by: Snircova E., et al.
Published: (2012-12-01)

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009-2011. An Update for Clinicians
by: Chris J. Bushe Mbbs, et al.
Published: (2011-01-01)

Case report: Treatment of persistent atypical odontalgia with attention deficit hyperactivity disorder and autism spectrum disorder with risperidone and atomoxetine
by: Satoshi Kasahara, et al.
Published: (2022-07-01)

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine
by: Imagawa H, et al.
Published: (2018-02-01)